Medpace Holdings Stock Today
| MEDP Stock | USD 338.96 0.00 0.00% |
Performance0 of 100
| Odds Of DistressLess than 1
|
Medpace Holdings is selling at 338.96 as of the 28th of November 2024; that is No Change since the beginning of the trading day. The stock's last reported lowest price was 333.5. Medpace Holdings has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Note, on August 15, 2024, Representative Josh Gottheimer of US Congress acquired under $15k worth of Medpace Holdings's common stock.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 11th of August 2016 | Category Healthcare | Classification Health Care |
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company was founded in 1992 and is based in Cincinnati, Ohio. Medpace Holdings operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. The company has 31.08 M outstanding shares of which 1.1 M shares are now shorted by private and institutional investors with about 2.71 trading days to cover. More on Medpace Holdings
Moving against Medpace Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Medpace Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| President | Susan Burwig | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Life Sciences Tools & Services, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Biotechnology, NASDAQ Composite, SP Midcap 400, Health Care, Life Sciences Tools & Services, Diagnostics & Research, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsMedpace Holdings can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Medpace Holdings' financial leverage. It provides some insight into what part of Medpace Holdings' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medpace Holdings (MEDP) is traded on NASDAQ Exchange in USA. It is located in 5375 Medpace Way, Cincinnati, OH, United States, 45227 and employs 5,900 people. Medpace Holdings is listed under Life Sciences Tools & Services category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 10.42 B. Medpace Holdings conducts business under Life Sciences Tools & Services sector and is part of Health Care industry. The entity has 31.08 M outstanding shares of which 1.1 M shares are now shorted by private and institutional investors with about 2.71 trading days to cover.
Medpace Holdings currently holds about 31.01 M in cash with 433.37 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.0.
Check Medpace Holdings Probability Of Bankruptcy
Ownership AllocationMedpace Holdings maintains a total of 31.08 Million outstanding shares. The majority of Medpace Holdings outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Medpace Holdings to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Medpace Holdings. Please pay attention to any change in the institutional holdings of Medpace Holdings as this could imply that something significant has changed or is about to change at the company. Also note that almost one million one hundred thirty-one thousand three hundred seventy invesors are currently shorting Medpace Holdings expressing very little confidence in its future performance.
Check Medpace Ownership Details
Medpace Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Bessemer Group Inc | 2024-06-30 | 484.5 K | |
| Findlay Park Partners Llp | 2024-09-30 | 470.9 K | |
| Capital World Investors | 2024-09-30 | 438.4 K | |
| Clearbridge Advisors, Llc | 2024-09-30 | 417.9 K | |
| Td Global Investment Solutions – Td Epoch | 2024-09-30 | 416.2 K | |
| American Capital Management Inc | 2024-09-30 | 380.6 K | |
| Aqr Capital Management Llc | 2024-06-30 | 310.6 K | |
| Wellington Management Company Llp | 2024-06-30 | 305.4 K | |
| Norges Bank | 2024-06-30 | 279.6 K | |
| Blackrock Inc | 2024-06-30 | 2.6 M | |
| Vanguard Group Inc | 2024-09-30 | 2.5 M |
Medpace Holdings Historical Income Statement
Medpace Stock Against Markets
Medpace Holdings Corporate Management
| Kevin Brady | CFO Treasurer | Profile | |
| Brandon Ebken | Chief Officer | Profile | |
| August MD | Chairman CEO | Profile | |
| Stephen JD | General Officer | Profile | |
| Stephen Ewald | General Counsel, Corporate Secretary | Profile | |
| Todd Meyers | Vice Marketing | Profile |
Additional Tools for Medpace Stock Analysis
When running Medpace Holdings' price analysis, check to measure Medpace Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medpace Holdings is operating at the current time. Most of Medpace Holdings' value examination focuses on studying past and present price action to predict the probability of Medpace Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medpace Holdings' price. Additionally, you may evaluate how the addition of Medpace Holdings to your portfolios can decrease your overall portfolio volatility.